Lurasidone Pediatric Bipolar Study

NCT02046369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Depression

Interventions

DRUG: Lurasidone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.